Long-Term Survival and Immune Response Dynamics in Melanoma Patients Undergoing TAPCells-Based Vaccination Therapy

Long-Term Survival and Immune Response Dynamics in Melanoma Patients Undergoing TAPCells-Based Vaccination Therapy

Cancer vaccines present a promising avenue for treating immune checkpoint blockers (ICBs)-refractory patients, fostering immune responses to modulate the tumor microenvironment. We revisit a phase I/II trial using Tumor Antigen-Presenting Cells (TAPCells) (NCT06152367), an autologous antigen-present...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Andrés Tittarelli, Cristian Pereda, María A. Gleisner, Mercedes N. López, Iván Flores, Fabián Tempio, Alvaro Lladser, Adnane Achour, Fermín E. González, Claudia Durán-Aniotz, Juan P. Miranda, Milton Larrondo, Flavio Salazar-Onfray
Format: Artikel
Sprache:English
Veröffentlicht: MDPI AG 2024-03-01
Schriftenreihe:Vaccines
Schlagworte:
immunotherapy
vaccine
melanoma
dendritic cell
clinical trials
compassionate use
Online Zugang:https://www.mdpi.com/2076-393X/12/4/357

Online

https://www.mdpi.com/2076-393X/12/4/357

Ähnliche Einträge